Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

The REPLACE Registry for Cholbam® (Cholic Acid)

ClinicalTrials.gov ID: NCT03115086

Public ClinicalTrials.gov record NCT03115086. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam® (Cholic Acid)

Study identification

NCT ID
NCT03115086
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Mirum Pharmaceuticals, Inc.
Industry
Enrollment
55 participants

Conditions and interventions

Interventions

  • Cholbam Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 9, 2017
Primary completion
Jun 30, 2038
Completion
Jun 30, 2039
Last update posted
Oct 1, 2023

2017 – 2039

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
University of Alabama Birmingham Birmingham Alabama 35233
Stanford School of Medicine Palo Alto California 94305
UC San Francisco San Francisco California 94158
Kidz Pediatric Multispecialty Group Hollywood Florida 33021
Nemours duPont Pediatrics Specialty Clinic Jacksonville Florida 32207
Nicklaus Children's Hospital Miami Florida 33155
Children's Healthcare of Atlanta Atlanta Georgia 30329
Children's Center For Digestive Health Atlanta Georgia 30342
The Community Health Clinic Topeka Indiana 46571
Ochsner Hospital for Children New Orleans Louisiana 70121
University of Minnesota Minneapolis Minnesota 55454
Mayo Clinic Rochester Minnesota 55902
Office of Dr. Esperanza Font-Montgomery MD Columbia Missouri 65201
Washington University at St Louis St Louis Missouri 63110
Icahn School Of Medicine at Mount Sinai New York New York 10029
Montefiore Medical Center New York New York 10032
Golisano Children's Hospital, URMC Rochester New York 14642
UNC Chapel Hill Chapel Hill North Carolina 27599
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
University of Oklahoma Oklahoma City Oklahoma 73104
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Monroe-Carell Jr. Children's Hospital at Vanderbilt Nashville Tennessee 37232
Primary Children's Hospital Salt Lake City Utah 84113

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03115086, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03115086 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →